Communiqués Aptevo Therapeutics Inc.

Actions

APVO

US03835L3069

Marché Fermé - Nasdaq Autres places de cotation 19:30:00 03/07/2024			Varia. 5j.	Varia. 1 janv.
0,313 ^USD	+5,03%		-40,04%	-96,07%

28/06	Les actions d'Aptevo chutent après la fixation du prix d'une offre d'actions de 2,8 millions de dollars	MT
08/05	Aptevo Therapeutics Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Aptevo Therapeutics Announces Closing of $2.75 Million Offering	02/07	AQ
Aptevo Therapeutics : Failure to Satisfy Listing Rule Form 8 K	01/07	PU
Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update	09/05	AQ
Alligator Bioscience AB reports financial results for Q1 2024 and provides a business update	06/05	AQ
Aptevo Therapeutics : 2024 Shareholder Letter	26/04	PU
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering	16/04	AQ
Aptevo Therapeutics Announces Pricing of $4.6 Million Public Offering	12/04	AQ
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4	07/03	AQ
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update	06/03	AQ
Alligator Bioscience AB reports full year financial results for 2023 and for Q4 2023 and provides a business update	08/02	AQ
Aptevo Therapeutics Reports 3Q23 Financial Results and Provides a Business Update	15/11	AQ
Aptevo to Present at Bio-Europe Conference	02/11	AQ
Aptevo Therapeutics : 28 August 2023 Investor Presentation	28/08/23	PU
Aptevo Therapeutics Reports 2Q23 Financial Results and Provides a Business Update	11/08/23	AQ
Aptevo Therapeutics Inc. Announces Closing of Previously Announced $5 Million Public Offering	07/08/23	AQ
Aptevo Therapeutics : Material Agreement - Form 8-K	07/08/23	PU
CapitalGainsReport Nanocap News Catalyst Watchlist (EPAZ, SIDU, MMMM, APVO)	20/07/23	AQ
Aptevo Announces Positive Duration of Remission Data from Phase 1b Expansion Trial Evaluating the Bispecific APVO436 for AML	19/07/23	AQ
Aptevo Therapeutics : New Data Adds to Growing Body of Clinical Evidence in Support of APVO436 Clinical Potential - Form 8-K	18/07/23	PU
Aptevo Therapeutics : 11 July 2023 Investor Presentation	11/07/23	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Aptevo Therapeutics Inc.

Actions

APVO

US03835L3069

Communiqués

Filtres